23andMe Investor Presentation Deck

Leaders in Data 23andMe Has the Largest Recontactable Genetic Database for Target Discovery in the World Largest, most diverse recontactable database of genotyped + phenotyped individuals 23and Me REGENERON MILLION VETERAN PROGRAM UK BIOBANK DECODE GENETICS FINNGEN ALL OF US GENOMICS ENGLAND ¹ As of September 30, 2023. -2M+ 900,000+ 500,000 500,000 473,000+ 413,000+ 100,000 *Publications supporting human genetic evidence for approved drug indications Nelson et al., 2015 (Nature Genetics); King et al., 2019 (PLOS Genetics) ~80% consent to research 14M¹ Pharma partnerships leverage the database for research and recruitment Target discovery Target validation Patient selection Clinical trial recruitment GSK Janssen Drugs with human genetic support are 2x - 3x Copyright © 2024 23and Me, Inc. more likely to succeed* Genentech Pfizer 23andMe 6

View entire presentation